Kocabas, N. A. 2012. Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD). CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS , vol.11, no.3 , 264-272.

Kocabas, N. A., (2012). Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD). CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS , vol.11, no.3, 264-272.

Kocabas, Neslihan. "Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD)," CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS , vol.11, no.3, 264-272, 2012

Kocabas, Neslihan A. . "Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD)." CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS , vol.11, no.3, pp.264-272, 2012

Kocabas, N. A. (2012) . "Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD)." CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS , vol.11, no.3, pp.264-272.

@article{article, author={Neslihan Aygun Kocabas}, title={Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD)}, journal={CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS}, year=2012, pages={264-272} }